In-vitro Evaluation of Antiviral Activity of Moringa oleifera Extracts against Polio virus
Journal of Pharmaceutical Research International,
Background: Moringa oleifera plant parts extract have been utilized tremendously in traditional medicine, having various pharmaceutical activities such as antifungal, antibacterial and antiviral properties.
Aim: This study was carried out to evaluate antiviral activity of aqueous extract of Moringa leaves, seeds and flowers against Polio virus isolates (Vaccine Strains P1&P3), MDG-17-04852; MDG-17-04881.
Study Design: This is a baseline study carried out to determine the efficacy of Moringa oleifera in the treatment of poliomyelitis.
Place and Duration of Study: This study was carried out at the University of Maiduguri Teaching Hospital Maiduguri and Abubakar Tafawa Balewa University, Bauchi from September 2018 to October, 2019.
Methods: Phytochemical substances was extracted and screened from the Moringa using standard laboratory techniques. Continuous cell line L20B cells was used to isolate polio virus. Polio virus stock was prepared and titration was carried out to determine TCID50 by Kerber’s formula, L-d(S - 0.5). Cytotoxicity of the extracts was evaluated using the end-point cytopathic effect assay. Antiviral assay and Polio virus Intratypic Differentiation (ITD) was performed using Real-Time PCR.
Results: The results revealed present of Tannins in leaves and flowers, Alkaloids and Saponins in all the extracts, Glycosides and Steroids in leaves and Flavonoids in flowers only. Cytotoxicity of the extracts shows 50% effects in 100mg and 50mg concentrations, while 33.3% and 16.7% was observed in 25mg and 12.5mg (P>.05). The titration of the tissue culture infective dose 50% (TCID50) shows that Polio virus type 1and 3 had a titre value of 106.5 and 106.25 respectively. The ITD results observed presence of Sl1 and Sl3 from the extracts.
Conclusion: This study found that the Moringa extracts did not neutralized the Polio virus strains studied, as the phytochemicals show no antiviral activity. Therefore further study is needed in this area to ascertain its antiviral potentials against poliomyelitis.
- Moringa oleifera
- phytochemical constituents
- polio virus
- cytopathic effect.
How to Cite
Edziri H, Mastouri M, Mahjoub MA, Ammar S, Mighri Z, Gutmann L, Aouni M. Antiviral activities of leaves extracts of Marrubium alysson L. J Med Plants Res. 2011;5(3): 360-363.
Ruwali P, Rai N, Kumar N, Gautam P. Antiviral potential of medicinal plants: An overview. Int Res J Pharm. 2013;4(6):8-16.
Balasubramanian K, Jayalakshmi N, Vidhya R.Antiviral activity of ancient system of Ayurvedic medicinal plant Cissus quadrangularis L. (Vitaceae) J Basic Clin Pharm. 2007;9:37- 40.
Merina N, Chandra KJ. Jibon K. Medicinal plant with potential anticancer activities. A Review. Int Res J Pharm. (2012; 3(6): 26-30.
Fahey JW. Moringa oleifera: A review of the medical evidence for its nutritional, therapeutic, and prophylactic properties. Part 1. Trees Life J. 2005; 1:5.
Grubben G, Grubben GJ. (Ed). Vegetables. 2 (Plant resources of tropical Africa). 2004; 394.
Anwar FS, Latif MA, Gilani AH. Moringa oleifera: A food plant with multiple medicinal uses. Phytother Res. 2007; 21: 17–25.
Vázquez-León LA, Páramo-Calderón DE, Robles-Olvera VJ, Valdés-Rodríguez OA, Pérez-Vázquez A, García-Alvarado MA, Rodríguez-Jimenes GC. Variation in Bioactive Compounds and Antiradical Activity of Moringa oleifera Leaves: Influence of Climatic Factors, Tree Age, and Soil Parameters. Europ Food Res Technol; 2017. Available:https://doi.org/10.1007/s00217-017-2868-4
Dayrit FM, Angela AD, Villasena IM. Studies on Moringa oleifera seeds part 1. The antibiotic compound and its deactivation sin aqueous solution. Philipp J Sci. 1990; 119(1):23-32.
Carceres AA, Sarawia S, Rizzo L, Zabala E, Nove F. Pharmacological properties of Moringa oleifera II: screening for antispasmodic, anti-inflammatory and diuretic activity. J ethno-pharma. 1992; 36(3):233-237.
Ezeamuzie TC, Amberkedeme AW, Shode FO, Ekwebelem SC. Anti-inflammatory effects of Moringa oleifera root. Int J Pharmacog. 1996; 34(93):207-212.
Kewo De L, Yang CF, Nottay B, Pallansch, M, Da Silver E. The role of virologic surveillance in the global initiative to eradicate poliomyelitis: in control of viral disease, 2ndedn (Ed. E. Kustark), marcel dekar New York. 1995; 215-246.
Ryan KJ, Ray CG. (Eds.) “Enteroviruses”. Sherri’s Medical Microbiology (4th Ed.). McGraw Hill. 1993; 535-537.
Pipkins PA. Characterisation of L cells expressing the human poliovirus receptor for the Specific detection of polioviruses in Vitro. J Virol. Methods. 1993; 41:333-340.
Mueller S, Wimmer E, Cello J. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Res. 2005; 111(2):175-93.
DavisL, BodianD, Price D, Butler I. Vickers J. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N Engl J Med. 1977; 297(5):241-45.
Miller A. Incidence of poliomyelitis; the effect of tonsillectomy and other operations on the nose and throat. Calif Med, 1952; 77(1):19-21.
Horstmann D. Acute poliomyelitis relation of physical activity at the time of onset to the course of the disease. J Am Med Assoc. 1950; 142(4):236-41.
Evans C. Factors influencing the occurrence of illness during naturally acquired poliomyelitis virus infections. Bact Rev. 1960; 24(4):341-52.
Sauerbrei A, Groh A, Bischoff A, Prager J, Wutzler P. Antibodies against vaccine-preventable diseases in pregnant women and their offspring in the eastern part of Germany. Med Microbiol and Immunol. 2002; 190(4):167–72.
Okoye EL. Inhibition of the poliomyelitis viral–induced cytopathic effect by extracts of Moringa oleifera Lam. Austr J Herb Med. 2014; 26(3):95-99.
World Health Organization, WHO. Polio laboratory manual WHO/IVB/04.10, 4th edn. WHO Department of Immunization, Vacand Biolog, Geneva; 2004;
Salama MA. Morpho-anatomical variations of leaves and seeds among three Moringa species. Life Sci J. 2014; 11(10):827-832.
Ramachandran C, Peter KV, Gopalakrishnan PK. Drumstick (M. oleifera): A multipurpose Indian vegetable: Econ Bot. 1980; 34(3):276-283.
Nanfack P, Biapa N, Pieme C, Ama M, Moukette BNgogang Y. The In vitro antisickling and antioxidant effects of aqueous extracts Zanthoxyllum heitziion sickle cell disorder. BMCCompl. Alt Med. 2013; 13:162.
World Health Organization. Polio laboratory manual WHO/IVB/04.10, 4th edn. WHO Department of Immunization, Vaccines and Biologicals, Geneva; 2004.
Jerrold HZ. Biostatistical Analysis (5th Edition). Prentice Hall Publishers. 2007;27-34.
Haristoy X, Fahey JW, Scholtus I. Lozniewski A. Evaluation of antimicrobial effect of several isothiocyanates on Helicobacter pylori. Plant and Med. 2005; 71:326-330.
Sabale V, Patel V, Paranjape A, Arya C, Sakarkar SN. Sabele PM. Moringa oleifera (Drumstick): An overview. Pharmacog. Rev. Suppl. 2008; 2:7–13.
Bennett RN, Mellon, FA, Foidl N, Pratt JH, Dupont MS, Perkins L. Profiling glucosinolates and phenolics in vegetative and reproductive tissues of the multi-purpose trees Moringa oleifera L. (Horseradish tree) and Moringa stenopetala L. J Agric. and Food Chem. 2003; 51:3546-3553.
Anwar F, Bhangar MI. Analytical characterization of Moringa oleifera seed oil growth in temperate regions of Pakistan. J Agric. and Food Chem. 2003; 22:6558-63.
Chollom SC, Agada GO, Gotep JG, Mwankon SE, Dus, PC, Bot YS. Investigation of aqueous extract of Moringa oleifera Lam seed for antiviral activity against Newcastle disease virus in ovo. J Med Plants Res. 2012; 6:3870-3875.
IshratI, Imran A, Muhammad A, Aqeel J, Neelma M, Rasheeda B. In vitro evaluation of antiviral activity of leaf extracts of Azadirachta indica, M. oleifera, and Morus alba against the foot and mouth disease virus on BHK-21 cell line. Nig J Microbiol. 2016;31(4):332-339.
World Health Organization, WHO. Vaccines for routine use. International travel and health; 2007.
Abstract View: 240 times
PDF Download: 183 times